Dr. Patricia Eshaghian joins us to discuss how this new drug is giving new hope to individuals dealing with this debilitating and sometimes deadly disease. She calls the drug a "tremendous breakthrough" for the rare genetic disease, which usually affects the lungs and creates a thick sticky mucus in them. She explains this can lead to having multiple breathing treatments, infections and sometimes hospitalizations.
She notes the drug brings treatment to the underlying genetic cause of the disease, saying 90 percent of people with cystic fibrosis will be a candidate for this new drug.
The drug is able to improve lung function by 10 to 14 percent in patients who take it, which might not seem major, but Dr. Eshaghian explains this is actually very significant. She adds, "This drug is going to change the way people live their life with cystic fibrosis," explaining it should lead to living longer and spending less time in the hospital.
Currently, the drug costs $300,000 dollars a year, but Dr. Eshaghian is hopeful insurance coverage for the drug will be good.